CAESAREA, Israel - IceCure Medical Ltd. , developer of the ProSense System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal,.
OraSure Technologies (NASDAQ:OSUR – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Valuation & Earnings This table compares OraSure […]
IceCure Medical Ltd. has announced that the Food and Drug Administration (FDA) has granted its appeal and reopened its De Novo Classification Request for Marketing Authorization of its ProSense cryoablation technology for early-stage breast cancer.
Icecure Medical Regains Compliance With Nasdaq Minimum Closing Bid Price Rule menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
CAESAREA, Israel, Jan. 12, 2024 IceCure Medical Ltd. , developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to.